CVS vs. HIMS: CVS Health vs. Hims & Hers Health Stock Comparison

Company Profile

CVS Health (CVS) and Hims & Hers Health (HIMS) are both classified in the Health Care Services sub-industry within the broader Health Care Providers & Services industry, placing them in the closest GICS peer bucket.

CVS Health (CVS) has more than two decades of public-market history since February 21, 1973, whereas Hims & Hers Health (HIMS) listed on September 13, 2019 and has a much shorter record to draw on.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Hims & Hers Health (HIMS) has a highly aggressive beta of 2.42, indicating much higher sensitivity to broad-market moves, while CVS Health (CVS) is defensive at 0.59 and tends to be less market-sensitive — a wide gap in beta profiles.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Hims & Hers Health (HIMS) reports a negative ROE of -2.66%; negative ROE can reflect losses or negative shareholders’ equity, so it is harder to read as capital efficiency. Meanwhile CVS Health (CVS) reports 6.21%, ranking against industry peers normally.

Hims & Hers Health (HIMS) reports a negative net margin of -0.56%, usually indicating a net loss over the period. Meanwhile CVS Health (CVS) reports 1.19%, ranking against industry peers normally.

Hims & Hers Health (HIMS) reports a negative operating margin of -7.90%, usually indicating that operating costs exceeded revenue at the operating-income line. Meanwhile CVS Health (CVS) reports 3.86%, ranking against industry peers normally.

Profitability Metrics

Growth

Hims & Hers Health (HIMS) at 59.00% clears its industry range for revenue growth, far stronger top-line momentum than CVS Health (CVS) at 7.85%, which is closer to a typical peer reading.

Hims & Hers Health (HIMS) at -3.77% is around its peer norm for EPS growth, while CVS Health (CVS) at -62.02% drops into the bottom quartile, signaling weaker earnings momentum.

Growth Metrics

Financial Strength

Hims & Hers Health (HIMS) at 1.69 keeps current ratio within its industry’s typical mid-range, while CVS Health (CVS) at 0.87 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for CVS.

CVS Health (CVS) at 0.96 is near its industry mid-range for debt-to-equity ratio, while Hims & Hers Health (HIMS) at 2.54 sits above its benchmark range, pointing to a heavier debt load relative to equity.

Financial Strength Metrics

Dividends

Hims & Hers Health (HIMS) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile CVS Health (CVS) reports a yield of 2.76%, ranking against industry peers normally.

Hims & Hers Health (HIMS) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile CVS Health (CVS) reports a payout of 70.18%, ranking against industry peers normally.

Dividend Metrics

Valuation

An earnings multiple is available for just one side: CVS Health (CVS) trades at 25.38 times trailing earnings, ranked against its peers, while Hims & Hers Health (HIMS) has no P/E ratio this period.

CVS Health (CVS) at 0.30 sits in the cheaper P/S ratio quartile while Hims & Hers Health (HIMS) at 3.09 prices around its industry’s middle — CVS costs less per dollar of sales, though read it alongside growth and margins.

CVS Health (CVS) at 1.53 sits in the lower P/B ratio quartile relative to book while Hims & Hers Health (HIMS) at 16.33 prices above its industry range — a wide valuation gap against assets.

Valuation Metrics